 |
|
|
| |
Rilpivirine population pharmacokinetic modeling in
antiretroviral-naïve, HIV-1-infected adolescents in PAINT
|
| |
| |
Reported by Jules Levin
16th International Workshop on Clinical Pharmacology of HIV and Hepatitis Therapy, Washington, WA, USA, May 26-28 2015
Anne Brochot, Annemie Hoogstoel, Simon Vanveggel, Marita Stevens, Herta M Crauwels
Janssen Infectious Diseases BVBA, Beerse, Belgium
CROI/2014: Rilpivirine pharmacokinetics in HIV-1-infected adolescents:
a substudy of PAINT (Phase II trial).......http://www.natap.org/2014/CROI/croi_174.htm
|
| |
|
|
|
|
|
